BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35033089)

  • 1. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
    J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
    Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
    J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 4. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
    Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
    BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy.
    Zhao Z; Wu J; Liu X; Liang M; Zhou X; Ouyang S; Yao J; Wang J; Luo B
    Cancer Lett; 2018 May; 421():73-81. PubMed ID: 29458142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
    Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
    Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy.
    Hu J; Hu J; Wu W; Qin Y; Fu J; Zhou J; Liu C; Yin J
    Acta Biomater; 2022 Oct; 151():588-599. PubMed ID: 36002126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation triggers the migration of hepatocellular carcinoma cells by suppressing miR-148a-5p.
    Wang H; Cao Y; Hu K; Li Q; Yang Y; Wang L; Qin X; Qiao B; Cheng L; Li P; Dui W
    Biol Chem; 2020 Jul; 401(8):985-994. PubMed ID: 32142478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy.
    Huang Y; Xu Z; Wei Y; Han S; Cai X; Chen D
    AAPS PharmSciTech; 2022 Apr; 23(4):111. PubMed ID: 35411416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting N
    Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
    Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
    Dong S; Li Z; Kong J; Wu S; Gao J; Sun W
    Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop.
    Wang X; Deng Q; Feng K; Chen S; Jiang J; Xia F; Ma K; Bie P
    Oncol Rep; 2018 Jul; 40(1):241-251. PubMed ID: 29749472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
    Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
    J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
    J Nanobiotechnology; 2022 Apr; 20(1):175. PubMed ID: 35366895
    [No Abstract]   [Full Text] [Related]  

  • 19. Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma.
    Tang Y; Shu Z; Zhu M; Li S; Ling Y; Fu Y; Hu Z; Wang J; Yang Z; Liao J; Xu L; Yu M; Peng Z
    Adv Healthc Mater; 2023 Dec; 12(30):e2302013. PubMed ID: 37665720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.